Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Visit
ESMO 2021
;
⏰ #ESMOBreast24 is just a week away!
We’re excited to bring you the latest news in #breastcancer at http://VJOncology.com, and follow us @VJOncology for exclusive interviews with experts, podcasts, and more!
@myESMO #bcsm
⏳We’re eagerly counting down the days until #ASCO24!
⭐From May 31st to June 4th, experts will be updating us on the latest, cutting-edge #HemOnc research – watch this space!
➡️ http://vjoncology.com/⬅️
🎥@MarianaBrandao0 of @JulesBordet addresses challenges in timely care for stage III #lungcancer patients, stressing the need for improved access to diagnostics and functional assessments for better surgical outcomes:
➡️⬅️
@BTOGORG #BTOG24 #LCSM
Challenges in timely assessment and access to care for lung cancer
Mariana Brandao, MD, PhD, from the Institute Jules Bordet in Brussels, Belgium, discusses the challenges in timely a...
ow.ly
🎥@gwalls89 of @QUBelfast sheds light on the NI-HEART analysis tackling cardiac toxicity post-radiotherapy for #lungcancer:
➡️⬅️
#BTOG24 @BTOGORG #LCSM
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
Gerard Walls, MB MRCP MSc FRCR, Queens University in Belfast, UK, discusses the NI-HEART analysis aimed at addressin...
ow.ly
🎥@AdamJanuszewski of @BartsHospital shares insights from a session at #BTOG24 on novel therapeutics for #lungcancer, including ADCs and BiTEs, highlighting promising trials and challenges ahead:
➡️⬅️
@BTOGORG #LCSM #ImmunoOnc
Exploring novel therapeutics in lung cancer: insights from BTOG 2024
Adam Januszewski, St Bartholomew's Hospital in London, provides an overview of a session he chaired at the BTOG 20...
ow.ly
ESMO 2021
⏰ #ESMOBreast24 is just a week away!
We’re excited to bring you the latest news in #breastcancer at http://VJOncology.com, and follow us @VJOncology for exclusive interviews with experts, podcasts, and more!
@myESMO #bcsm
⏳We’re eagerly counting down the days until #ASCO24!
⭐From May 31st to June 4th, experts will be updating us on the latest, cutting-edge #HemOnc research – watch this space!
➡️ http://vjoncology.com/⬅️
🎥@MarianaBrandao0 of @JulesBordet addresses challenges in timely care for stage III #lungcancer patients, stressing the need for improved access to diagnostics and functional assessments for better surgical outcomes:
➡️⬅️
@BTOGORG #BTOG24 #LCSM
Challenges in timely assessment and access to care for lung cancer
Mariana Brandao, MD, PhD, from the Institute Jules Bordet in Brussels, Belgium, discusses the challenges in timely a...
ow.ly
🎥@gwalls89 of @QUBelfast sheds light on the NI-HEART analysis tackling cardiac toxicity post-radiotherapy for #lungcancer:
➡️⬅️
#BTOG24 @BTOGORG #LCSM
Addressing challenges in collecting cardiac toxicity data: NI-HEART analysis
Gerard Walls, MB MRCP MSc FRCR, Queens University in Belfast, UK, discusses the NI-HEART analysis aimed at addressin...
ow.ly
🎥@AdamJanuszewski of @BartsHospital shares insights from a session at #BTOG24 on novel therapeutics for #lungcancer, including ADCs and BiTEs, highlighting promising trials and challenges ahead:
➡️⬅️
@BTOGORG #LCSM #ImmunoOnc
Exploring novel therapeutics in lung cancer: insights from BTOG 2024
Adam Januszewski, St Bartholomew's Hospital in London, provides an overview of a session he chaired at the BTOG 20...
ow.ly
